232 related articles for article (PubMed ID: 35721085)
1. The Genetic Landscape of Cutaneous Lupus Erythematosus.
Chen HW; Barber G; Chong BF
Front Med (Lausanne); 2022; 9():916011. PubMed ID: 35721085
[TBL] [Abstract][Full Text] [Related]
2. Immunogenetics of cutaneous lupus erythematosus.
Hersh AO; Arkin LM; Prahalad S
Curr Opin Pediatr; 2016 Aug; 28(4):470-5. PubMed ID: 27386968
[TBL] [Abstract][Full Text] [Related]
3. Current Knowledge of the Molecular Pathogenesis of Cutaneous Lupus Erythematosus.
Miyagawa F
J Clin Med; 2023 Jan; 12(3):. PubMed ID: 36769633
[TBL] [Abstract][Full Text] [Related]
4. Bioinformatics analyses of gene expression profile identify key genes and functional pathways involved in cutaneous lupus erythematosus.
Gao ZY; Su LC; Wu QC; Sheng JE; Wang YL; Dai YF; Chen AP; He SS; Huang X; Yan GQ
Clin Rheumatol; 2022 Feb; 41(2):437-452. PubMed ID: 34553293
[TBL] [Abstract][Full Text] [Related]
5. Long-Term Risk of Autoimmune Diseases other than Systemic Lupus Erythematosus in Cutaneous Lupus Erythematosus-Alone Patients: A 10-Year Nationwide Cohort Study.
Lin TL; Wu CY; Juan CK; Chang YT; Chen YJ
Dermatology; 2022; 238(1):92-100. PubMed ID: 34062538
[TBL] [Abstract][Full Text] [Related]
6. New insights into the progression from cutaneous lupus to systemic lupus erythematosus.
Zhou W; Wu H; Zhao M; Lu Q
Expert Rev Clin Immunol; 2020 Aug; 16(8):829-837. PubMed ID: 32746644
[TBL] [Abstract][Full Text] [Related]
7. Pathogenesis of cutaneous lupus erythema associated with and without systemic lupus erythema.
Zhang YP; Wu J; Han YF; Shi ZR; Wang L
Autoimmun Rev; 2017 Jul; 16(7):735-742. PubMed ID: 28483542
[TBL] [Abstract][Full Text] [Related]
8. Molecular Profiling of Cutaneous Lupus Lesions Identifies Subgroups Distinct from Clinical Phenotypes.
Berthier CC; Tsoi LC; Reed TJ; Stannard JN; Myers EM; Namas R; Xing X; Lazar S; Lowe L; Kretzler M; Gudjonsson JE; Kahlenberg JM
J Clin Med; 2019 Aug; 8(8):. PubMed ID: 31426521
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide association study identifies new susceptibility loci for cutaneous lupus erythematosus.
Kunz M; König IR; Schillert A; Kruppa J; Ziegler A; Grallert H; Müller-Nurasyid M; Lieb W; Franke A; Ranki A; Panelius J; Koskenmies S; Hasan T; Kere J; Rönn AC; Simon JC; Schmidt E; Wenzel J; Tüting T; Landsberg J; Zeller T; Blankenberg S; Gläser R; Patsinakidis N; Kuhn A; Ibrahim SM
Exp Dermatol; 2015 Jul; 24(7):510-5. PubMed ID: 25827949
[TBL] [Abstract][Full Text] [Related]
10. Role of biomarkers in the diagnosis and prognosis of patients with cutaneous lupus erythematosus.
Zhu JL; Black SM; Chong BF
Ann Transl Med; 2021 Mar; 9(5):429. PubMed ID: 33842650
[TBL] [Abstract][Full Text] [Related]
11. The combination of complement deficiency and cigarette smoking as risk factor for cutaneous lupus erythematosus in men; a focus on combined C2/C4 deficiency.
Boeckler P; Milea M; Meyer A; Uring-Lambert B; Heid E; Hauptmann G; Cribier B; Lipsker D
Br J Dermatol; 2005 Feb; 152(2):265-70. PubMed ID: 15727637
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous lupus erythematosus: An update.
Grönhagen CM; Nyberg F
Indian Dermatol Online J; 2014 Jan; 5(1):7-13. PubMed ID: 24616847
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous lupus erythematosus without systemic lupus erythematosus: clinical and laboratory features.
Wallace DJ; Pistiner M; Nessim S; Metzger AL; Klinenberg JR
Semin Arthritis Rheum; 1992 Feb; 21(4):221-6. PubMed ID: 1570517
[TBL] [Abstract][Full Text] [Related]
14. The interferon-regulated gene signature is elevated in subacute cutaneous lupus erythematosus and discoid lupus erythematosus and correlates with the cutaneous lupus area and severity index score.
Braunstein I; Klein R; Okawa J; Werth VP
Br J Dermatol; 2012 May; 166(5):971-5. PubMed ID: 22242767
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory and T Helper 17/ Regulatory T Cells Related Cytokines Balance in Cutaneous Lupus Erythematosus (CLE).
Yazdani MR; Aflaki E; Gholijani N
Iran J Allergy Asthma Immunol; 2020 Feb; 19(1):9-17. PubMed ID: 32245325
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous lupus erythematosus and systemic lupus erythematosus are associated with clinically significant cardiovascular risk: a Danish nationwide cohort study.
Hesselvig JH; Ahlehoff O; Dreyer L; Gislason G; Kofoed K
Lupus; 2017 Jan; 26(1):48-53. PubMed ID: 27235406
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous lupus erythematosus and the association with systemic lupus erythematosus: a population-based cohort of 1088 patients in Sweden.
Grönhagen CM; Fored CM; Granath F; Nyberg F
Br J Dermatol; 2011 Jun; 164(6):1335-41. PubMed ID: 21574972
[TBL] [Abstract][Full Text] [Related]
18. Dermatologic Manifestations, Histologic Features and Disease Progression among Cutaneous Lupus Erythematosus Subtypes: A Prospective Observational Study in Asians.
Chanprapaph K; Tankunakorn J; Suchonwanit P; Rutnin S
Dermatol Ther (Heidelb); 2021 Feb; 11(1):131-147. PubMed ID: 33280074
[TBL] [Abstract][Full Text] [Related]
19. Increased risk of depression in patients with cutaneous lupus erythematosus and systemic lupus erythematosus: a Danish nationwide cohort study.
Hesselvig JH; Egeberg A; Kofoed K; Gislason G; Dreyer L
Br J Dermatol; 2018 Nov; 179(5):1095-1101. PubMed ID: 29885269
[TBL] [Abstract][Full Text] [Related]
20. Type I Interferon as cardiovascular risk factor in systemic and cutaneous lupus erythematosus: A systematic review.
Kirchler C; Husar-Memmer E; Rappersberger K; Thaler K; Fritsch-Stork R
Autoimmun Rev; 2021 May; 20(5):102794. PubMed ID: 33722754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
